Chinese biotech versus international ethics? Accounting for the China–America CRISPR ethical divide

The role of scientific self‐regulation for the control of genome editing in the human germline

“…When a team of researchers from Sun Yat‐sen University in Guangdong used the CRISPR‐Cas9 technology to modify a disease‐causing gene in human embryos, they restricted their experiment by using non‐viable tri‐pronuclear zygotes . However, even this self‐restriction did not go far enough for Nature and Science, which both rejected their study . Although the results were eventually published elsewhere , the initial rejections demonstrate the influence of journals on the conduct of research.…”